Laserfiche WebLink
HF100 NINTH ENGROSSMENT REVISOR BD 1-10100-9 <br />114.1 Sec. 55. [342.55] DUTIES OF HEALTH CARE PRACTITIONERS; REGISTRY <br />114.2 PROGRAM. <br />114.3 Subdivision 1. Health care practitioner duties before patient enrollment. Before a <br />114.4 patient's enrollment in the registry program, a health care practitioner must: <br />114.5 (1) determine, in the health care practitioner's medical judgment, whether a patient has <br />114.6 a qualifying medical condition and, if so determined, provide the patient with a certification <br />114.7 of that diagnosis; <br />114.8 (2) advise patients, registered designated caregivers, and parents, legal guardians, and <br />114.9 spouses acting as caregivers of any nonprofit patient support groups or organizations; <br />114.10 (3) provide to patients explanatory information from the Division of Medical Cannabis, <br />114.11 including information about the experimental nature of the therapeutic use of medical <br />114.12 cannabis flower and medical cannabinoid products; the possible risks, benefits, and side <br />114.13 effects of the proposed treatment; and the application and other materials from the office; <br />114.14 (4) provide to patients a Tennessen warning as required under section 13.04, subdivision <br />114.15 2; and <br />114.16 (5) agree to continue treatment of the patient's qualifying medical condition and to report <br />114.17 findings to the Division of Medical Cannabis. <br />114.18 Subd. 2. Duties upon patient's enrollment in registry program. Upon receiving <br />114.19 notification from the Division of Medical Cannabis of the patient's enrollment in the registry <br />114.20 program, a health care practitioner must: <br />114.21 (1) participate in the patient registry reporting system under the guidance and supervision <br />114.22 of the Division of Medical Cannabis; <br />114.23 (2) report to the Division of Medical Cannabis patient health records throughout the <br />114.24 patient's ongoing treatment in a manner determined by the office and in accordance with <br />114.25 subdivision 4: <br />114.26 (3) determine on a yearly basis if the patient continues to have a qualifying medical <br />114.27 condition and, if so, issue the patient a new certification of that diagnosis. The patient <br />114.28 assessment conducted under this clause may be conducted via telehealth, as defined in <br />114.29 section 62A.673, subdivision 2; and <br />114.30 (4) otherwise comply with requirements established by the Office of Cannabis <br />114.31 Management and the Division of Medical Cannabis. <br />Article 1 Sec. 55. 114 <br />